Cost-benefit analysis and joint availability measures
β Scribed by M.N. Gopalan; S.S. Waghmare
- Publisher
- Elsevier Science
- Year
- 1986
- Tongue
- English
- Weight
- 218 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0026-2714
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract When health effects can be valued in monetary terms, as in costβbenefit analysis, they should be discounted at the same rate as costs. If health effects are measured in quantities (e.g. quality adjusted life years) as in costβeffectiveness analysis (CEA) and the value of health effects
## When benefit-cost analysis produces a result that is objectionable does this mean that the technique is objectionable? It means only that the technique cannot rise above the individual and community values on which it rests. That is, values in benefit-cost analysis rest in large measure on law.